Compare Smith & Nephew plc (SNN) vs T Rowe Price Group Inc (TROW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smith & Nephew plc vs T Rowe Price Group Inc — how do they compare? Smith & Nephew plc trades at $27.24 (market cap $11.10B), while T Rowe Price Group Inc trades at $105.16 (market cap $22.23B). The key difference: T Rowe Price Group Inc is far larger — about 2× Smith & Nephew plc's market cap, and T Rowe Price Group Inc pays the higher dividend (4.99%). Which is the better fit depends on your goals — on Pluang, investors hold Smith & Nephew plc for 121 Days and T Rowe Price Group Inc for 115 Days on average.
| SNN | TROW | |
|---|---|---|
Market Cap | $11.10B | $22.23B |
Volume | 1,051,703 | 2,834,949 |
Sector | Health | Financials |
52-Week High | $37.17 | $121.68 |
52-Week Low | $26.42 | $86.19 |
Typical Hold Time | 121 Days | 115 Days |
Enterprise Value | $14.13B | $19.43B |
Dividend Yield | 2.95% | 4.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Smith+Nephew (SNN) trades at $27.24, near its 52-week low of $27.05, with a bearish technical signal despite recent earnings beats. Revenue grew to $6.16B in 2025, with net income margin improving to 10.08%, but the stock faces headwinds from analyst downgrades and CFO departure news. Product launches like the EVOS PELVIC System highlight innovation, yet investor sentiment remains cautious.
The outlook is mixed: strong fundamentals and undervaluation (P/E 18.34) offer upside, but technical weakness and competitive risks temper near-term gains. Key risks include execution challenges and market volatility, while institutional interest (e.g., BlackRock's $505M stake) provides support. Investors should weigh solid profitability against sentiment-driven price pressure.
T. Rowe Price (TROW) trades at $105.16, up 1.05% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong fundamentals with $7.31B revenue, 29.26% net margin, and attractive valuation at 10.46 P/E. Recent earnings show two beats out of three quarters, while assets under management reached $1.90T in August 2026 despite net outflows.
TROW presents a compelling value opportunity with solid dividend growth and reasonable valuation, though technical weakness and analyst caution warrant attention. The stock's 40-year dividend growth history and expanding ETF offerings through F/m Investments acquisition provide stability, while market volatility and fee pressure remain key risks for the asset management business.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →About T Rowe Price Group Inc
T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load U.S. and international stock, hybrid, bond, and money market funds. At the end of August 2022, the firm had $1.339 trillion in managed assets, composed of equity (54%), balanced (30%), fixed-income (13%), and alternatives (3%) offerings. Approximately two thirds of the company's managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a U.S.-based asset manager, deriving just under 10% of its AUM from overseas.
Read more on TROW →
